/ Browse·page 718 of 1630

Browse EX-10 agreements

19,554 total material contract exhibits.

Filters

EX-10.3

REALLOYS INC.

Certain personal identifying information has been excluded from this exhibit pursuant to Item 601(a)(6) of Regulation S-K. Redacted information is indicated by [***]. EMPLOYMENT AGREEMENT This Employment Agreement ("Agreement") is entered into as of 10 August 2026, between: Employer: REalloys Canada Inc., a corporation incorporated under the laws of Canada and a wholly-owned subsidiary of REalloys Inc. (NASDAQ: ALOY) (the "Company") — and — Employee: Muhammad Imran, residing at [***] ("Employee") The Company and the Employee are referred to individually as a "Party" and collectively as the "Parties". In consideration of the mutual covenants set out in this Agreement, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged), the Parties agree as follows. Schedule B (Summary of Compensation Terms) is attached hereto, incorporated by reference, and forms part of this Agreement. 1. POSITION The Company agrees to employ the Employee as "Chief Operating Officer" of REalloys Inc. and its consolidated subsidiaries and operations ("COO") commencing on the Effective Date. The Employee will report to the Chief Executive Officer of REalloys Inc. ("CEO"). The Employee will be expected to perform the duties and exercise the powers customarily associated with the COO role of a publicly listed critical minerals company, including day-to-day operational leadership, oversight of engineering and processing operations, capital project execution, supply-chain management, and such other duties as the CEO or the Board of Directors of REalloys

…

Open document
EX-10.3·10-Q·CIK 1567900·ACC 0001628280-26-056817·Filed Aug 13, 2026, 17:05 ET

EX-10.2

REALLOYS INC.

Certain personal identifying information has been excluded from this exhibit pursuant to Item 601(a)(6) of Regulation S-K. Redacted information is indicated by [***]. REALLOYS INC. Chief Financial Officer Consulting Agreement Between REalloys Inc. and Provenance Advisors Effective Date: June 24, 2026


REalloys Inc. Chief Financial Officer Consulting Agreement This Chief Financial Officer Consulting Agreement is entered into as of June 24, 2026 by and between REalloys Inc., a Nevada corporation listed on NASDAQ under the symbol ALOY, and Provenance Advisors Inc. (the “Consultant”). REalloys Inc. and its subsidiaries are referred to collectively as the “Company.” The Company desires to retain the Consultant to provide services as the Company's Chief Financial Officer on an independent contractor basis, and the Consultant desires to provide those services on the terms set forth in this Agreement. Accordingly, the parties agree as follows. 1. Engagement and Appointment 1.1 Appointment The Company hereby retains the Consultant to provide the services of Chief Financial Officer of the Company. Subject to Board approval and applicable securities law disclosure requirements, Craig Cunningham shall be appointed as Chief Financial Officer and principal financial officer of the Company for SEC, NASDAQ, and public company reporting purposes. The Consultant shall report directly to the Chief Executive Officer and to the Board of Directors. The Consultant shall have direct access to the Audit Committee, the Chair of the Audit Committee,

…

Open document
EX-10.2·10-Q·CIK 1567900·ACC 0001628280-26-056817·Filed Aug 13, 2026, 17:05 ET

MUTUAL TERMINATION AND RELEASE AGREEMENT

This MUTUAL TERMINATION AND RELEASE AGREEMENT (the “Agreement”), dated as of August 13, 2026 (the “Effective Date”), is entered into by and among Old Glory Holding Company, a Delaware corporation, registered as a Bank Holding Company under the Bank Holding Company Act of 1956 (“Old Glory”) and Digital Asset Acquisition Corp, a Cayman Islands exempted company (“DAAQ”) (collectively, the “Parties”).

RECITALS

WHEREAS, on January 13, 2026, the Parties entered into a Business Combination Agreement (the “Business Combination Agreement”), pursuant to which, among other things, DAAQ was to domesticate as a Texas corporation and thereafter, Old Glory would merge with and into DAAQ;

WHEREAS, pursuant to Section 8.1(a) of the Business Combination Agreement, the Business Combination Agreement may be terminated at any time prior to the Closing by mutual written consent of DAAQ and Old Glory;

WHEREAS, the Parties have mutually agreed to terminate the Business Combination Agreement and abandon the Transactions as of the Effective Date; and

WHEREAS, the Board of Directors of each Party has (i) determined that it is advisable and in the best interest of such Party and its stockholders to enter into this Agreement and (ii) approved the execution, delivery and performance by such Party of this Agreement and the transactions contemplated hereby.

STATEMENT OF AGREEMENT

…

Open document
EX-10.1·8-K·CIK 2052162·ACC 0001213900-26-089219·Filed Aug 13, 2026, 17:02 ET

Option Agreement

Z Squared Inc.

OPTION AGREEMENT

(GEAR Therapeutics Inc.)

This OPTION AGREEMENT (“Agreement”) is made and entered into as of April 24 , 2026 (the “Effective Date”), by and between Coeptis Therapeutics Holdings, Inc., a Delaware corporation (“Seller”), and Coeptis Holdings, Inc., a Delaware corporation (including its designee(s), “Option Holder”). GEAR Therapeutics, Inc., a Florida corporation (“Company”) is also a party to this Agreement.

** **

WHEREAS, Seller is currently the sole owner of 8,300,00 shares of the Company’s Class A Voting Common Stock, which Class A Voting Common Stock represent 100% of the issued and outstanding shares of Class A Voting Common Stock and 83% of the issued and outstanding ownership interests of the Company (such shares of Class A Voting Common Stock, the “Seller Interests”);

** **

WHEREAS, Seller wishes to grant to Option Holder, and Option Holder wishes to accept from Seller, on the terms and subject to the conditions set forth in this Agreement, an option to purchase the Seller Interests.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Seller and Option Holder agree hereby as follows:

ARTICLE I. INTERPRETATIONS; DEFINITIONS.

** **

…

Open document
EX-10.27·10-Q·CIK 1759186·ACC 0001185185-26-003508·Filed Aug 13, 2026, 17:01 ET

** **

Assignment and Assumption Agreement

This Assignment and Assumption Agreement (this “Agreement”), dated and effective as of April 15, 2026 (the “Effective Date”), is by and between Coeptis Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), and Coeptis Therapeutics, Inc., a Delaware corporation (“Subsidiary”).

** **

WHEREAS, the Company is a biopharmaceutical company which owns, acquires, and develops innovative cell therapy platforms for cancer, autoimmune, and infectious diseases;

** **

WHEREAS, Subsidiary is a wholly-owned subsidiary of the Company; and

** **

WHEREAS, the Company and Subsidiary desire to enter into this Agreement pursuant to which the Company will convey certain of its biopharmaceutical operations assets and liabilities to Subsidiary and Subsidiary will accept such conveyance (the “Assignment”).

** **

NOW, THEREFORE, in consideration of the mutual covenants, terms and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

…

Open document
EX-10.26·10-Q·CIK 1759186·ACC 0001185185-26-003508·Filed Aug 13, 2026, 17:01 ET

Contribution Agreement

This Contribution Agreement (this “Agreement”), dated and effective as of April 15, 2026 (the “Effective Date”), is by and between Coeptis Therapeutics Holdings Inc., a Delaware corporation (the “Company”), and Coeptis Holdings, Inc., a Delaware corporation ( “Spin Out Sub”).

WHEREAS, the Company is a biopharmaceutical company which owns, acquires, and develops innovative cell therapy platforms for cancer, autoimmune, and infectious diseases;

WHEREAS, Spin Out Sub, in connection with the transactions contemplated hereby, will become a wholly-owned subsidiary of the Company; and

WHEREAS, the Company and Spin Out Sub desire to enter into this Agreement pursuant to which the Company will (i) convey to Spin Out Sub certain equity securities held by the Company, as a capital contribution to Spin Out Sub and (ii) become the sole stockholder of Spin Out Sub, on the terms and subject to the conditions set forth in this Agreement (the “Contribution”).

NOW, THEREFORE, in consideration of the mutual covenants, terms and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

…

Open document
EX-10.25·10-Q·CIK 1759186·ACC 0001185185-26-003508·Filed Aug 13, 2026, 17:01 ET

Release Agreement

MapLight Therapeutics, Inc.

RELEASE AGREEMENT

My employment with MapLight Therapeutics, Inc. (the “Company”) terminated on June 18, 2026 (the “Separation Date”). I confirm that I have been paid all compensation owed to me for all hours worked for the Company through the Separation Date; I received all the leave and leave benefits and protections for which I was eligible during my employment; and I have not suffered any on-the-job injury for which I have not already filed a claim.

I represent that I have returned all Company equipment, property and documents and any other embodiments of the Company’s proprietary or confidential information (and all reproductions thereof, in whole or in part) (“Company Property”) previously in my possession or control. I acknowledge and agree to continue to abide by my continuing obligations under my Employee Confidential Information, Inventions, Non-Solicitation and Non-Competition Agreement.

In exchange for me returning this fully executed Release Agreement (the “Agreement”) to the Company within five (5) business days after I receive it and abiding by its terms, and provided that I timely elect continued coverage under COBRA (or a state equivalent), the Company will pay my COBRA group health insurance premiums for me and my eligible dependents until the earliest of: (a) September 30, 2026; (b) the expiration of my eligibility for continued coverage under COBRA; or (c) the date I become eligible for health insurance coverage in connection with new employment or self-employment.

…

Open document
EX-10.1·10-Q·CIK 1770069·ACC 0001193125-26-349554·Filed Aug 13, 2026, 17:01 ET

Execution Version

SECOND AMENDMENT TO REVOLVING CREDIT AND GUARANTY AGREEMENT

SECOND AMENDMENT TO CREDIT AGREEMENT, dated as of August 10, 2026 (this “Amendment”), by and among Cloudflare, Inc., a Delaware corporation (the “Borrower”), the Guarantors (as defined in the Credit Agreement referenced below), the Lenders (as defined below) party hereto and Citibank, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”).

W I T N E S S E T H:

WHEREAS, inter alios, the Borrower, each Guarantor, the lenders from time to time party thereto (the “Lenders”) and the Administrative Agent have entered into that certain Revolving Credit and Guaranty Agreement, dated as of May 17, 2024 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time through the date hereof, the “Credit Agreement”; capitalized terms not otherwise defined in this Amendment having the same meanings assigned thereto in the Credit Agreement);

WHEREAS, pursuant to Section 10.2 of the Credit Agreement, the Borrower has requested that the Credit Agreement be amended as more fully described herein and the Lenders party hereto, which constitute the Required Lenders, are so willing to amend the Credit Agreement on the terms and subject to the conditions set forth herein;

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of all of which is hereby acknowledged, the parties hereto hereby agree as follows:

…

Open document
EX-10.2·8-K·CIK 1477333·ACC 0000950103-26-012340·Filed Aug 13, 2026, 17:01 ET

[_________]1

To: Cloudflare, Inc. 101 Townsend Street San Francisco, California 94107
From: [__________]
Re: [Base]2[Additional]3 Capped Call Transaction
Ref. No: [__________]4
Date: [_______], 2026

Dear Ladies and Gentlemen:

The purpose of this communication (this “Confirmation”) is to set forth the terms and conditions of the above-referenced transaction entered into on the Trade Date specified below (the “Transaction”) between [___________] (“Dealer”)[, represented by [_________] (“Agent”) as its agent,] and Cloudflare, Inc. (“Counterparty”).  This communication constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below.

…

Open document
EX-10.1·8-K·CIK 1477333·ACC 0000950103-26-012340·Filed Aug 13, 2026, 17:01 ET

PURCHASE AGREEMENT

NOCERA, INC.

** **

HUD - 1 (3 - 86) RESPA, HB4305.2 OMB NO. 2502 - 0265 B. TYPE OF LOAN: A. U.S. DEPARTMENT OF HOUSING & URBAN DEVELOPMENT SETTLEMENT STATEMENT 5. CONV. INS. 1. FHA 2. FmHA 3. X CONV. UNINS. 4. VA 7. LOAN NUMBER: 6934100 6. FILE NUMBER: MTE - 26 - 9336 RUDDER 8. MORTGAGE INS CASE NUMBER: C. NOTE: This form is furnished to give you a statement of actual settlement costs. Amounts paid to and by the settlement agent are shown. Items marked "[POC]" were paid outside the closing; they are shown here for informational purposes and are not included in the totals. 1.0 3/98 (MTE - 26 - 9336 RUDDER.PFD/MTE - 26 - 9336 RUDDER/9) F. NAME AND ADDRESS OF LENDER: Alabama Ag Credit, ACA E. NAME AND ADDRESS OF SELLER: Nocera, Inc. D. NAME AND ADDRESS OF BORROWER: Timothy Lowry Rudder and Catherine Leddy Rudder I. SETTLEMENT DATE: August 7, 2026 H. SETTLEMENT AGENT: 81 - 4721792 Crum, Ellis & Associates, P.C. G. PROPERTY LOCATION: 231 +/ - acres Montgomery County, AL Montgomery County, Alabama PLACE OF SETTLEMENT 641 S. Lawrence St. Montgomery, AL 36104 K. SUMMARY OF SELLER'S TRANSACTION J. SUMMARY OF BORROWER'S TRANSACTION 400. GROSS AMOUNT DUE TO SELLER: 100. GROSS AMOUNT DUE FROM BORROWER: 700,000.00 401. Contract Sales Price 700,000.00 101. Contract Sales Price 402. Personal Property 102. Personal Property 403. 8,636.50 103. Settlement Charges to Borrower (Line 1400) 404. 104. 405. 105. Adjustments For Items Paid By Seller in advance Adjustments For Items Paid By Seller in advance 406. City/Town Taxes to to 106. City/Town Taxes 407. County Taxes to to 107. County Taxes 408.

…

Open document
EX-10.1·8-K·CIK 1756180·ACC 0001683168-26-006346·Filed Aug 13, 2026, 17:00 ET

EX-10.4

PETMED EXPRESS INC

4936-4559-0698.5 AMENDMENT NO. 1 TO INTERIM EXECUTIVE EMPLOYMENT AGREEMENT This is Amendment No. 1, dated August 10, 2026 (this “Amendment No. 1”), to the Interim Executive Employment Agreement, dated October 25, 2025 (the “Employment Agreement”), between PETMED EXPRESS, INC., a Florida corporation (the “Company”), and LESLIE C. G. CAMPBELL, an individual (the “Executive”). Capitalized terms used in this Amendment No. 1 and not otherwise defined herein shall have the meanings ascribed thereto in the Employment Agreement. Background WHEREAS, pursuant to the terms of the Employment Agreement, Executive is employed as the Interim Chief Executive Officer and President of the Company; and WHEREAS, the Company and the Executive desire to hereby amend Section 3 and Section 4(a) of the Employment Agreement, as set forth below. NOW, THEREFORE, the parties hereto intending to be legally bound hereby, and in consideration of the mutual covenants herein contained, agree as follows: Terms 1. Section 3 of the Employment Agreement is hereby deleted in its entirety and replaced with the following: 3. TERM OF EMPLOYMENT. Executive’s employment commenced on August 11, 2025 and shall continue under this Agreement until terminated in accordance with Section 4 of this Agreement (the “Term of Employment”). 2. Section 4(a) of the Employment Agreement is hereby deleted in its entirety and replaced with the following: (a) At-Will Employment. Executive’s employment by Company is on an “at- will” basis and may be immediately terminated at any time and for any reason (with or without cause) by

…

Open document
EX-10.4·10-Q·CIK 1040130·ACC 0001040130-26-000041·Filed Aug 13, 2026, 16:58 ET

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

** **

PROMISSORY NOTE

** **

Principal Amount: US$8,253.03

Dated: August 11, 2026

New York, New York

FOR VALUE RECEIVED, Eureka Acquisition Corp (the “Maker” or the “Company”) promises to pay to the order of Marine Thinking Inc., or its registered assignees or successors in interest (the “Payee”), the principal sum of USD EIGHT THOUSAND TWO HUNDRED FIFTY-THREE AND THREE HUNDREDTHS ONLY (US$8,253.03), on the terms and conditions described below. All payments on this Note shall be made by wire transfer of immediately available funds to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this note (the “Note”).

…

Open document
EX-10.1·8-K·CIK 2000410·ACC 0001213900-26-089205·Filed Aug 13, 2026, 16:57 ET